HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuo Ito Selected Research

BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

3/2018Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: long-term follow-up of the Japanese subgroup of the randomized ENESTnd trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuo Ito Research Topics

Disease

3Splenomegaly
02/2018 - 03/2015
2Primary Myelofibrosis (Myelosclerosis)
07/2015 - 03/2015
2Bone Resorption
11/2013 - 01/2007
2Neoplasms (Cancer)
01/2007 - 04/2002
2Neoplasm Metastasis (Metastasis)
01/2007 - 04/2002
1Blast Crisis (Blast Phase)
03/2018
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2018
1Pruritus (Itching)
02/2018
1Polycythemia Vera
02/2018
1Leukemia
05/2017
1Chondrosarcoma
07/2014
1Body Weight (Weight, Body)
07/2013
1Atherosclerosis
04/2009
1Breast Neoplasms (Breast Cancer)
01/2007
1Bone Diseases (Bone Disease)
01/2007
1Multiple Myeloma
01/2007
1Mitral Valve Insufficiency (Mitral Regurgitation)
06/2006
1Left Ventricular Outflow Obstruction
06/2006
1Diabetic Foot
02/2005
1Wounds and Injuries (Trauma)
02/2005
1Heart Failure
10/2003
1Lung Neoplasms (Lung Cancer)
04/2002
1Hypoxia (Hypoxemia)
04/2002
1Tendon Injuries
01/2002
1Cicatrix (Scar)
01/2002

Drug/Important Bio-Agent (IBA)

3ruxolitinibIBA
02/2018 - 03/2015
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
05/2017 - 02/2005
1Imatinib Mesylate (Gleevec)FDA Link
03/2018
1nilotinibFDA Link
03/2018
1Hydroxyurea (Hydrea)FDA LinkGeneric
02/2018
1Bone Morphogenetic Protein 2IBA
05/2017
1Janus Kinase InhibitorsIBA
07/2015
1Janus Kinase 1IBA
07/2015
1Janus KinasesIBA
03/2015
1Aggrecans (Aggrecan)IBA
07/2014
1collagen type I trimeric cross-linked peptideIBA
11/2013
1Collagen Type I (Type I Collagen)IBA
11/2013
1Alkaline PhosphataseIBA
11/2013
1Biomarkers (Surrogate Marker)IBA
11/2013
1Galanin-Like PeptideIBA
07/2013
1Estrogens (Estrogen)FDA Link
04/2009
1DenosumabFDA Link
01/2007
1CalciumIBA
01/2007
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
10/2003
1Glucose (Dextrose)FDA LinkGeneric
10/2003
1Indicators and Reagents (Reagents)IBA
10/2003
1Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA
10/2003
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
04/2002
1Proteins (Proteins, Gene)FDA Link
04/2002
1Plasminogen Activators (Plasminogen Activator)IBA
04/2002
1Plasminogen Activator Inhibitor 1IBA
04/2002
1Messenger RNA (mRNA)IBA
04/2002
1CollagenIBA
01/2002

Therapy/Procedure

3Therapeutics
02/2018 - 01/2007
1Subcutaneous Injections
01/2007
1Cardiopulmonary Bypass (Heart-Lung Bypass)
06/2006